Skip to main content
FF

Foundation for the Advancement of Clinical TMS (FACTMS)

We offer advanced mental health treatments, including transcranial magnetic stimulation (TMS) and neurofeedback, for conditions like depression, anxiety, ADHD, and PTSD. Our specialized therapies aim to provide faster and more effective relief compared to traditional approaches.

Brentwood, United StatesFounded 202211500+ followers
Updated 3 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Traditional mental health treatments often provide slow or incomplete relief for conditions like depression, anxiety, ADHD, and PTSD. Many patients require more advanced interventions than standard medication and therapy can provide.

Solution

Fermata offers specialized psychiatric services, including advanced neuromodulation therapies and medication management, to address a range of mental health conditions. The practice utilizes techniques such as Transcranial Magnetic Stimulation (TMS), SAINT™ (Stanford Accelerated Intelligent Neuromodulation Therapy), and PRISM Neurofeedback to target specific brain circuits and improve treatment outcomes. Fermata also provides medication management, Spravato® (Esketamine) treatments, and other therapies tailored to individual patient needs, offering comprehensive and innovative approaches to mental healthcare.

Target Audience

Fermata serves individuals seeking advanced mental health treatments for conditions such as depression, anxiety, ADHD, and PTSD, including those who have not found sufficient relief from traditional therapies.

Features

  • Transcranial Magnetic Stimulation (TMS) for Major Depressive Disorder and OCD, utilizing advanced protocols including accelerated TMS and deep TMS with fMRI guidance.
  • SAINT™ (Stanford Accelerated Intelligent Neuromodulation Therapy) for treatment-resistant depression.
  • PRISM Neurofeedback for PTSD, training patients to control neural connections between the amygdala and frontal cortex.
  • Monarch eTNS® (External Trigeminal Nerve Stimulation) for ADHD in children ages 7-12, a non-invasive neuromodulation therapy.
  • GammaCore™ nVNS (non-invasive Vagus Nerve Stimulation) for headaches, and investigational use for PTSD and anxiety.
  • Spravato® (Esketamine) treatment for treatment-resistant depression and suicidal ideation.
  • Second opinion consultations providing comprehensive diagnostic assessments and treatment recommendations.
This profile is AI-generated and may contain inaccuracies.